Dow Up0.76% Nasdaq Up0.69%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
123.68 Up 2.36(1.95%) Oct 24, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 113,020   119,377   123,551   79,088  
Cost of Revenue9,305  6,110  3,501   -  
Gross Profit 103,715   113,267   120,050   79,088  
Operating Expenses
Research Development45,668  35,292  10,506  10,920  
Selling General and Administrative95,097  59,750  24,113  14,742  
Non Recurring -   -   -   -  
Others154   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (37,204) 18,225   85,431   53,426  
Income from Continuing Operations
Total Other Income/Expenses Net(34)38   -   -  
Earnings Before Interest And Taxes(37,238)18,263  85,439  53,574  
Interest Expense -   -   -   -  
Income Before Tax(37,238)18,263  85,439  53,574  
Income Tax Expense(181)(12)21,202  11,241  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(37,057)18,275  64,237  42,333  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (37,057) 18,275   64,237   42,333  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (37,057) 18,275   64,237   42,333  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.